- Home
- CLNN vs ECOR Comparison
CLNN vs ECOR Comparison
Compare CLNN & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLNN | ECOR |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | 79 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.7M | 81.0M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | CLNN | ECOR |
|---|---|---|
| Price | $6.02 | $9.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $33.75 | $18.00 |
| AVG Volume (30 Days) | ★ 671.8K | 128.4K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | $17.64 | $33.60 |
| Revenue Next Year | $19,516.77 | $30.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $3.25 | $4.16 |
| 52 Week High | $13.50 | $10.27 |
Technical Indicators
Market Signals| Indicator | CLNN | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 44.04 | 78.75 |
| Support Level | $5.56 | $4.66 |
| Resistance Level | $6.92 | N/A |
| Average True Range (ATR) | 0.53 | 0.76 |
| MACD | -0.10 | 0.41 |
| Stochastic Oscillator | 14.69 | 91.58 |
Price Performance
Historical ComparisonAbout CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About ECOR electroCore Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.